Literature DB >> 1900158

Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5'-monophosphate against chronic and advanced stages of schistosomiasis.

M H el Kouni1.   

Abstract

The efficacy of the highly selective antischistosomal combination chemotherapy with tubercidin (7-deazaadenosine) plus nitrobenzylthioinosine 5'-monophosphate (NBMPR-P), [el Kouni et al., Proc Natl Acad Sci USA 80: 6667-6670, 1983; el Kouni et al., Biochem Pharmacol 36: 3815-3821, 1987] was examined against chronic and advanced stages of schistosomiasis in mice. Administration of four successive daily doses of tubercidin (5 mg/kg/day) plus NBMPR-P (25 mg/kg/day) to Schistosoma mansoni-infected mice beginning 5, 6, 7 and 8 weeks post-infection and monitored for 22 weeks was very effective against the parasite. It resulted in a marked increase in survivorship of treated mice. Repetition of the dose-regimen after a 10-day rest period was even more effective. However, survivorship of infected animals decreased with the delay of therapy. Early treatment (5 weeks post-infection) resulted in 100% survival compared to 13% only for untreated animals. If therapy was instituted at 8 weeks post-infection, only 70% of the treated mice survived. Treated animals appeared healthy and were found to have less splenomegaly and hepatomegaly. Combination therapy also caused a significant reduction in the number of worms as well as the number of eggs in the liver and small intestine. However, these differences diminished as the treatment was delayed. The number of eggs in the liver was reduced from an average of 120,000 eggs per liver in untreated animals to approximately 16,000 eggs per liver when treated at 5 weeks post-infection. When treatment was delayed to 8 weeks post-infection, the reduction in liver egg count was not as dramatic (88,000 eggs per liver). Similarly, the number of eggs was reduced in the intestine from 1,759 to an average of 58 and 860 eggs per cm2 of the intestine when the mice were treated at 5 and 8 weeks post-infection respectively. However, some worms survived and resumed egg production after an extended period of recuperation. Histological examination indicated that combination therapy was effective in preventing the formation of new egg granulomas but not on pre-existing granulomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900158     DOI: 10.1016/0006-2952(91)90085-j

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

Review 1.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

2.  Isolation and substrate specificity of an adenine nucleoside phosphorylase from adult Schistosoma mansoni.

Authors:  Todd M Savarese; Mahmoud H El Kouni
Journal:  Mol Biochem Parasitol       Date:  2014-04-30       Impact factor: 1.759

3.  Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.

Authors:  M H el Kouni; V Guarcello; O N Al Safarjalani; F N Naguib
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Efficacy of the tubercidin antileishmania action associated with an inhibitor of the nucleoside transport.

Authors:  J I Aoki; E H Yamashiro-Kanashiro; D C C Ramos; P C Cotrim
Journal:  Parasitol Res       Date:  2008-09-12       Impact factor: 2.289

5.  Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.

Authors:  Omar N Al Safarjalani; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

6.  Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.

Authors:  Laising Yen; Maxime Magnier; Ralph Weissleder; Brent R Stockwell; Richard C Mulligan
Journal:  RNA       Date:  2006-03-23       Impact factor: 4.942

7.  Purine nucleoside phosphorylase from Schistosoma mansoni in complex with ribose-1-phosphate.

Authors:  Humberto D'Muniz Pereira; Glaucius Oliva; Richard Charles Garratt
Journal:  J Synchrotron Radiat       Date:  2010-11-12       Impact factor: 2.616

8.  Characterization of a Novel Endoplasmic Reticulum Protein Involved in Tubercidin Resistance in Leishmania major.

Authors:  Juliana Ide Aoki; Adriano Cappellazzo Coelho; Sandra Marcia Muxel; Ricardo Andrade Zampieri; Eduardo Milton Ramos Sanchez; Audun Helge Nerland; Lucile Maria Floeter-Winter; Paulo Cesar Cotrim
Journal:  PLoS Negl Trop Dis       Date:  2016-09-08

Review 9.  Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules.

Authors:  Maria João Gouveia; Paul J Brindley; Fátima Gärtner; José M Correia da Costa; Nuno Vale
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.